What is Tirzepatide / TZ GLP2?
Tirzepatide, also referred to in some research contexts as TZ-GLP2, is a synthetic peptide studied for its potential to influence metabolic regulation, blood sugar control, insulin sensitivity, and appetite modulation. It functions as a dual agonist of the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors—two key hormonal pathways involved in energy balance, glucose metabolism, and type 2 diabetes research.
In preclinical models, Tirzepatide has been investigated for its ability to support glycemic control and diabetes-related metabolic pathways, as well as for its role in weight management mechanisms and fat metabolism. Additional research has explored its effects on gut-brain signaling, digestive hormone response, and cellular energy regulation under controlled laboratory conditions
